Price $0.59 |
Market Cap
7.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
0.69
|
P/S
-
|
Dividend %
-
|
|
P/CF
1.1
|
P/FCF
-
|
Op. Cash Flow
-16.2K
|
FCF
-1.4
|
|
Op. Margin
-
|
Net Margin
-
|
ROE
-133.90%
|
ROI
-
|
|
ROA
-113.80%
|
EPS Growth
18.70%
|
Current Ratio
5.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| China Pharma Holdings, Inc. (CPHI) | $0.24 | - | - | 10M | Strong Buy |
| Reliv International, Inc (RELV) | $4.82 | - | - | 8.9M | Strong Buy |
| Acorda Therapeutics Inc (ACOR) | $28.75 | - | - | 1.32B | Strong Buy |
| AMAG Pharmaceuticals, Inc. (AMAG) | $21.85 | - | - | 683.1M | Strong Buy |
| Kalvista Pharmaceuticals Inc (KALV) | $8.70 | - | - | 87.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
